Search Within

Aseem Anand

Formats
  1. Meeting Abstract (42)
  2. Journal Article (19)
Groups
  1. Department of Medicine (52)
  2. Genitourinary Oncology Service (52)
  3. Solid Tumor Oncology Division (52)
  4. Epidemiology and Biostatistics (21)
  5. GSK Faculty (21)
  6. Biostatistics Service (20)

More Groups

People
  1. Howard Scher (46)
  2. Martin Fleisher (34)
  3. Daniel Danila (33)
  4. Glenn Heller (19)
  5. Michael Morris (15)
  6. Hans Lilja (10)

More People

Years
  1. 2025 (1)
  2. 2022 (3)
  3. 2020 (1)
  4. 2019 (2)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. Clinical Cancer Research (3)
  3. Journal of Nuclear Medicine (3)
  4. Clinical Chemistry (2)
  5. European Urology (2)
  6. Journal of Molecular Diagnostics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (35)
  2. Elsevier Science, Inc. (6)
  3. American Association for Cancer Research (5)
  4. Society of Nuclear Medicine (3)
  5. Springer (3)
  6. American Association for Clinical Chemistry (2)

More Publishers

Results (61)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in progressive metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Dittamore, R.; Louw, J.; Krupa, R.; Anand, A.; Danila, D. C.; Arslan, Z.; Bales, N.; Marrinucci, D.; Scher, H. I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Anand, A.; Krupa, R.; Louw, J.; Arslan, Z.; Dittamore, R.; Scher, H. I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival
    Journal Article

    Danila, D. C.; Anand, A.; Schultz, N.; Heller, G.; Wan, M.; Sung, C. C.; Dai, C.; Khanin, R.; Fleisher, M.; Lilja, H.; more...
    European Urology (2014)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Genomic heterogeneity of circulating tumor cells in castration-resistant prostate cancer (CRPC) revealed by single-cell sequencing
    Meeting Abstract

    Welsh, A.; Danila, D. C.; Anand, A.; Kendall, J.; Sawyers, C. L.; Fleisher, M.; Wigler, M.; Hicks, J. B.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Sera cytokine levels to predict survival in men with progressive castration-resistant prostate cancer
    Meeting Abstract

    Subudhi, S. K.; Heller, G.; Danila, D. C.; Anand, A.; Lacuna, K. P.; Samoila, A.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A pilot study comparing circulation tumor cells (CTC) detection by AdnaTest prostate assay to CellSearch in patients (pts) with castration resistant prostate cancer (CRPC)
    Meeting Abstract

    Samoila, A.; Bastos, D. A.; Herkal, A.; Patel, C.; Curtis, K. R.; Schreiber, N. A.; Anand, A.; Fleisher, M.; Scher, H. I.; Danila, D. C.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Anand, A.; Danila, D. C.; Heller, G.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Validation of the aDNA test prostate assay sensitivity in detecting prostate-associated transcripts compared to the veridex cellsearch enumeration assay in patients with prostate sancer
    Meeting Abstract

    Samoila, A.; Bastos, D. A.; Anand, A.; Herkal, A.; Patel, C.; Curtis, K. R.; Schreiber, N.; Fleisher, M.; Scher, H. I.; Danila, D. C.
    Journal of Molecular Diagnostics (2013)

    Fulltext@MSK | Save
  • The analytic validation of prostate-specific mRNA detection in whole blood by RT-PCR as a prognostic biomarker for patients with castration- resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save